🇺🇸 FDA
Patent

US 7915396

Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized antibody CC49

granted A61PA61P35/00

Quick answer

US patent 7915396 (Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized antibody CC49) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P35/00